CEO resigns at his own request in Isofol Medical AB (publ)
Gothenburg, Sweden, June 21, 2023 – Isofol Medical AB (publ) announces today that Thomas Andersson, at his own request, has chosen to resign as Chief Executive Officer of the company.The information in the press release is intended for investors. Isofol's CEO, Thomas Andersson, has today informed the board that he is leaving the position as Chief Executive Officer. The board will return with information about new CEO. For more information, please contact Isofol Medical AB (publ)Mats Franzén, chairman of the boardE-post: mats@efficere.se This information is information that